Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatase domain-containing protein 1 (PTPDC1) is a member of the protein tyrosine phosphatase (PTP) family, a group of enzymes involved in removing phosphate groups from phosphorylated tyrosine residues on proteins[1][3]. PTPs are crucial regulators in signal transduction pathways, cell cycle control, and other processes[1][5]. PTPDC1 contains the characteristic PTP motif and is suggested to play a role in cilia formation or maintenance, although its specific function and physiological roles remain unclear[3]. There are alternatively spliced transcript variants of PTPDC1, but no direct links to drugs, prominent disease roles, established biomarkers, or therapeutic safety issues are noted in the current literature[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase domain-containing protein 1 (PTPDC1).